Bladder Cancer: A Major Public Health Issue

European Urology, Supplements

Volumn 7, Issue 7, 2008, Pages 510-515

  Grasso, Marco ^a  

^a DESIO HOSPITAL   (Italy)

Author keywords

Bladder cancer; Epidemiology; Grade; Haematuria; Occupational exposure; Progression; Recurrence; Stage; Symptoms; Transitional cell carcinoma

Indexed keywords

BLADDER BIOPSY; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COST OF ILLNESS; CYSTOSCOPY; EARLY DIAGNOSIS; EUROPEAN UNION; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEMATURIA; HISTOPATHOLOGY; HUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; WORKPLACE;

EID: 43849088953     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2008.04.001     Document Type: Review

References (23)

1. Kirkali Z., Chan T., Murugesan M., et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66 Suppl 6A (2005) 4-34
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
3. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 16 (2004) 481-488
4. Ferlay J., Randi G., Bosetti C., et al. Declining mortality from bladder cancer in Europe. BJU Int 101 (2007) 11-19
5. Sant M., Aareleid T., Berrino F., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Urol 14 Suppl 5 (2003) v61-v118
6. Botteman M.F., Pashos C.L., Redaelli A., Laskin B., and Hauser R. The health economics of bladder cancer. A comprehensive review of the published literature. Pharmacoeconomics 21 (2003) 1315-1330
7. Sangar V.K., Ragavan N., Matanheleia S.S., Watson M.W., and Blades R.A. The economic consequences of prostate bladder cancer in UK. BJU Int 95 (2005) 59-63
8. Burger M., Zaak D., Stief C.G., et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 52 (2007) 142-147
9. Bruyninckx R., Buntinx F., Aertgeerts B., and Van Casteren V. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract 53 (2003) 31-35
10. Olfert S.M., Felknor S.A., and Delclos G.L. An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures. South Med J 99 (2006) 1256-1263
11. Kogevinas M., 't Mannetje A., Cordier S., et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 14 (2003) 907-914
12. Porru S., di Carlo A.S., Placidi D., Arici C., Tassi G., and Alessio L. Occupational cancer. The role of the occupational physician in systematic search and aetiological diagnosis of lung cancer. Analysis of a case list. Med Lav 97 (2006) 565-580
13. Allard P., Bernard P., Fradet Y., and Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 81 (1998) 692-698
14. Sylvester R.J. Natural history, recurrence, and progression in superficial bladder cancer. Scientific World J 27 (2006) 2617-2625
15. Fitzpatrick J.M., West A.B., Butler M.R., Lane V., and O'Flynn J.D. Special bladder tumors (stage pTa, grade 1 and 2): the importance of the recurrence pattern following initial resection. J Urol 135 (1986) 920-922
16. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J Urol 130 (1983) 1083-1086
17. Thompson R.A., Campbell Jr. E.W., and Kramer H.C. Late invasive recurrence despite long term surveillance for superficial cancer. J Urol 149 (1993) 1010
18. Chao D., Freedland S.J., Pantuck A.J., Zisman A., and Belldegrun A.S. Molecular markers for the diagnosis of transitional cell carcinoma. Rev Urol 3 (2001) 85-93
19. Herr H.W. Extravesical tumor relapse in patients with superficial bladder tumours. J Clin Oncol 16 (1998) 1099-1102
20. Van der Meijden A.P.M., Sylvester R., Oosterlinck W., et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48 (2005) 361-371
21. In: Sobin D.H., and Wittekind C.H. (Eds). TNM classification of malignant tumours. ed. 6 (2002), Wiley-Liss, New York 199-202
22. Lamm D. Bladder cancer: improving care with better classification and risk stratification. J Urol 178 (2007) 1146-1147
23. Schned A.R., Andrew A.S., Marsit C.J., Zens M.S., Kelsey K.T., and Karagas M.R. Survival following the diagnosis of non-invasive bladder cancer: WHO/International Society of Urological Pathology versus WHO Classification System. J Urol 178 (2007) 1196-1200